Chapter Nanotoxicity in cancer research: technical protocols and tips considerations for the use of 3D tumour spheroids
The poor clinical translation of oncological nanomedicine products is one of the greatest challenges faced by research today. The use of reductionist in vitro models of human cancer and non-predictive animal models is generally considered as one of the main causes of such very low translation rate....
Main Author: | Movia, Dania (auth) |
---|---|
Other Authors: | Prina-Mello, Adriele (auth) |
Format: | eBook |
Published: |
InTechOpen
2018
|
Subjects: | |
Online Access: | Get fulltext |
Similar Items
-
Macrophage Plasticity and Function in the Lung Tumour Microenvironment Revealed in 3D Heterotypic Spheroid and Explant Models
by: Lauren Evans, et al.
Published: (2021-03-01) -
Multicellular Tumour Spheroids in a Translational PET Imaging Strategy
by: Monazzam, Azita
Published: (2007) -
Cetuximab reconstitutes proinflammatory cytokine secretions and tumour-infiltrating capabilities of sMICA-inhibited NK cells in HNSCC tumour spheroids.
by: Stephan eKloess, et al.
Published: (2015-11-01) -
Fluorescence-Based Quantitative and Spatial Analysis of Tumour Spheroids: A Proposed Tool to Predict Patient-Specific Therapy Response
by: Loredana Spoerri, et al.
Published: (2021-05-01) -
Determining Conditions for Successful Culture of Multi-Cellular 3D Tumour Spheroids to Investigate the Effect of Mesenchymal Stem Cells on Breast Cancer Cell Invasiveness
by: Marie-Juliet Brown, et al.
Published: (2019-11-01)